TriSalus Life Sciences (TLSI) Income Statement: Revenue & Earnings

TriSalus Life Sciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

TriSalus Life Sciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	29.43	18.51	12.40	8.40	5.43
Cost of Revenue	4.10	2.61	2.26	1.19	2.20
Gross Profit	25.33	15.91	10.14	7.21	3.24
Operating Expenses
Research & Development	17.69	29.84	21.36	14.22	15.83
Selling, General & Administrative	43.81	36.25	25.22	17.02	13.06
Operating Expenses	61.49	66.08	46.58	31.24	28.88
Operating Income	-36.17	-50.18	-36.44	-24.03	-25.65
Other Income/Expense
Interest Income	0.40	0.43	0.18	0.00	0.00
Interest Expense	3.09	-0.02	0.00	1.76	-6.04
Other Income/Expense	8.81	-17.11	-10.92	-3.05	-0.14
Income
Income Before Tax	-30.04	-59.35	-47.18	-28.84	-31.83
Income Tax Expense	0.01	0.01	0.01	0.00	0.00
Net Income	-30.05	-59.36	-47.19	-28.85	-31.83
Net Income - Continuous Operations	-30.05	-59.36	-47.19	-28.85	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-26.21	-49.49	-36.04	-26.62	-25.33
EBIT	-26.95	-50.18	-36.44	-27.08	-25.65
Depreciation & Amortization	0.74	0.68	0.40	0.46	0.32
Earnings Per Share
Basic EPS	-1.00	-7.00	-162.00	-93.00	-4.00
Diluted EPS	-1.00	-7.00	-162.00	-93.00	-4.00
Basic Shares Outstanding	25.33	9.40	0.31	0.31	7.67
Diluted Shares Outstanding	25.33	9.40	0.31	0.31	7.67